Hopkins at Home: New Treatment for Depression

Description

For some people who suffer with severe treatment-resistant depression, there's good news. Esketamine is a groundbreaking therapy that may provide relief from major depression within hours. Psychiatrist Erica Richards describes who is a candidate for esketamine, which is derived from an anesthetic called ketamine, and how it works. Psychopharmacologist Roland Griffiths focuses on psilocybin research and risk factors of the drug.

This event is presented in partnership between Hopkins at Home with Johns Hopkins Medicine's A Woman's Journey.